BRIEF-Biofrontera: European Commission extends Ameluz approval to basal cell carcinoma
* European Commission extends Ameluz approval to basal cell carcinoma Source text for Eikon: Further company coverage: (Gdynia Newsroom) [Source]
Publication Date:Origin: reuters.com
Category: rbssHealthcareNews
Topics: basal, approval, Ameluz, extends, Commission, European, Newsroom), (Gdynia, coverage, company, Further, Eikon, carcinoma Source, carcinoma, BRIEF-Biofrontera
Source: http://feeds.reuters.com/~r/reuters/UShealthcareNews/~3/FqnDtPtSdX8/idUSFWN1FK0O7